CINECA IRIS Institutional Research Information System

STELLA, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.904
EU - Europa 5.005
AS - Asia 2.172
AF - Africa 51
SA - Sud America 45
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 22
Totale 14.223
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.827
IT - Italia 1.285
CN - Cina 944
RU - Federazione Russa 641
IE - Irlanda 638
SG - Singapore 532
SE - Svezia 531
FR - Francia 479
FI - Finlandia 335
DE - Germania 309
UA - Ucraina 278
KR - Corea 243
GB - Regno Unito 133
PL - Polonia 123
AT - Austria 116
VN - Vietnam 89
IN - India 88
JP - Giappone 78
CA - Canada 63
ID - Indonesia 54
ES - Italia 31
TW - Taiwan 29
HK - Hong Kong 27
BR - Brasile 22
EU - Europa 21
AU - Australia 19
BE - Belgio 19
NL - Olanda 18
IR - Iran 17
TR - Turchia 16
RO - Romania 15
MA - Marocco 14
MX - Messico 12
SN - Senegal 12
DZ - Algeria 11
NO - Norvegia 11
UZ - Uzbekistan 10
CO - Colombia 9
PT - Portogallo 8
CH - Svizzera 7
PK - Pakistan 7
TH - Thailandia 7
EG - Egitto 6
IL - Israele 6
JO - Giordania 6
AR - Argentina 5
NZ - Nuova Zelanda 5
CL - Cile 4
GR - Grecia 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
IQ - Iraq 3
LK - Sri Lanka 3
RS - Serbia 3
SA - Arabia Saudita 3
SI - Slovenia 3
BF - Burkina Faso 2
CY - Cipro 2
DK - Danimarca 2
EC - Ecuador 2
HU - Ungheria 2
LT - Lituania 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
Totale 14.223
Salva come PNG Salva come JPEG
Città #
Chandler 732
Dublin 638
Santa Clara 509
Beijing 434
Singapore 427
Torino 418
Fairfield 344
Jacksonville 322
Ann Arbor 317
Ashburn 317
Houston 304
Villeurbanne 258
Wilmington 237
Woodbridge 218
Medford 199
Princeton 189
Columbus 168
Nyköping 160
Seattle 154
Dearborn 152
Cambridge 131
Warsaw 118
Vienna 111
Pisa 92
Boston 77
Redwood City 67
Turin 62
Boardman 47
Dong Ket 46
Milan 46
Jakarta 44
Guangzhou 43
Rome 43
Shanghai 43
Norwalk 38
Hangzhou 36
Fremont 31
San Diego 30
Nanjing 29
Verona 27
Hefei 26
Munich 23
Helsinki 22
Shenyang 22
Taipei 22
New York 21
San Mateo 21
Toronto 21
Zhengzhou 20
Düsseldorf 17
London 17
Paris 16
Brussels 15
Lappeenranta 15
Ottawa 15
Phoenix 15
Hong Kong 14
Fuzhou 13
Jinan 13
Tokyo 13
Washington 13
Chengdu 12
Kunming 12
Xian 12
Falls Church 11
Pune 11
Reims 10
Siena 10
Upper Marlboro 10
Genova 9
Hebei 9
Mumbai 9
Oslo 9
Vancouver 9
Wuhan 9
Bologna 8
Gif-sur-yvette 8
Los Angeles 8
Nuremberg 8
Seoul 8
Suri 8
Catania 7
Harbin 7
Parma 7
Brisbane 6
Buffalo 6
Detroit 6
Groningen 6
Montreal 6
Moscow 6
Nanchang 6
Pescara 6
Piemonte 6
Taglio Di Po 6
Bari 5
Bogotá 5
Caluire-et-Cuire 5
Changsha 5
Chicago 5
Falkenstein 5
Totale 8.333
Salva come PNG Salva come JPEG
Nome #
Nanostructured delivery systems with improved leishmanicidal activity: a critical review 795
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 308
Caratterizzazione di nanoparticelle di polialchilcianoacrilato coniugate con l’acido folico 261
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 257
Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes 206
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 187
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells 185
Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative 182
Pentamidine-Loaded Lipid and Polymer Nanocarriers as Tunable Anticancer Drug Delivery Systems 179
Hyaluronan-decorated liposomes as drug delivery systems for cutaneous administration 171
Preparazione e caratterizzazione di liposomi convenzionali ed a lunga circolazione contenenti taxani 167
A unique squalenoylated and non pegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity 161
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 161
Advances in anticancer antibody-drug conjugates and immunotoxins. 157
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives. 155
Nanoparticles obtained by confined impinging jet mixer: poly(lactide-co-glycolide) vs. Poly-ε-caprolactone 155
Ruthenium polypyridyl squalene derivative: a novel self-assembling lipophilic probe for cellular imaging 154
Cyclopamine-paclitaxel-containing nanoparticles: internalization in cells detected by confocal and super-resolution microscopy 153
Hyaluronic acid-coated liposomes for active targeting of gemcitabine. 144
Peptide conjugation: before or after nanoparticle formation? 141
Rationally designed hyaluronic acid-based nano-complexes for pentamidine delivery 141
Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells 136
In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better. 130
Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes 125
Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates 124
Use of squalenic acid for the formulation of an active principle in nanoparticle state 121
Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits 120
Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice 117
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment 114
Production of PEGylated nanocapsules through solvent displacement in confined impinging jet mixers 109
Nanoparticles of therapeutic agents having low water solubility 108
Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles 105
Preparazione e caratterizzazione di liposomi convenzionali e a lunga circolazione contenenti taxani 103
Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate 102
Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates 101
Self-assembly drug conjugates for anticancer treatment 98
Anticancer prodrugs: an overview of major strategies and recent developments. 96
A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity. 95
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain 95
Biological characterization of folic acid-conjugated poly(H(2)NPEGCA-co-HDCA) nanoparticles in cellular models 93
Active targeting of squalenic nanoparticles 93
Investigation of squalene-doxorubicin distribution and interactions within single cancer cell using Raman microspectroscopy 92
Characterisation of folic acid-nanoparticles conjugates for tumoral targeting 90
Disulfiram liposomiale: una nuova strategia contro l’adenocarcinoma duttale del pancreas. 90
Strategies to control the particle size distribution of doxorubicin-containing polycyanoacrylate nanoparticles 88
Targeting of squalene nanoparticles 86
Biodegradable nanoparticles for drug delivery and targeting 86
Veicolazione di taxani in liposomi convenzionali ed a lunga circolazione 85
Hyaluronic acid for anticancer drug and nucleic acid delivery 84
Uptake and intracellular fate of biocompatible nanocarriers in cycling and noncycling cells 84
Squalenizzazione: nuova tecnica per nanoparticelle non polimeriche. 82
Biological characterisation of folic acid-conjugated nanoparticles in cellular models 81
Effect of mixing in the preparation of doxorubicin-loaded cyanoacrylate nanoparticles via solvent displacement 81
Cyclopamine-paclitaxel containing nanoparticles: internalization detection by confocal microscopy and super-resolution 81
Exploiting lipid and polymer nanocarriers to improve the anticancer sonodynamic activity of chlorophyll 81
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization 80
Synthesis, characterization and biological evaluation of new PEG-paclitaxel derivatives. 80
Gemcitabine derivatives nanoparticles 79
Elaboration of argan oil nanocapsules containing naproxen for cosmetic and transdermal local application 79
Synthesis of new gemcitabine prodrugs for liposome and nanoparticle encapsulation 78
Nonpolymeric nanoparticles for ocular administration of acyclovir 78
Squalene-doxorubicin: nanoassembly with superior anticancer activity and reduced toxicity. 77
Developing actively targeted nanoparticles to fight cancer: Focus on italian research 77
Stacking as a key property for creating nanoparticles with tunable shape: The case of squalenoyl-doxorubicin 76
Nanoparticle derivatives of gemcitabine 75
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery 75
Incorporation and release of gemcitabine prodrug in mesoporous silica nanoparticles 75
Design of folic acid-conjugated nanoparticles for drug targeting 74
Preparation of P(MePEGCA-co-HDCA) nanoparticles loaded with doxorubicin: mixing issues 74
Transfezione genica con vettori non virali 74
New difluoro-2'-deoxycytidine derivatives, useful as anticancer and antiviral agents, contain residue that promotes formation of nanoparticles and increases stability in serum 73
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization. 73
Incorporation and release of gemcitabine prodrug in mesoporous silica nanoparticles 73
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 71
Characterisation of folic acid-conjugated nanoparticles for tumoral targeting 70
Detection of flourescent nanoparticles containing squalene-cyclopamine and squalene-paclitaxel 70
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery 69
Nanomedicine for gene delivery and drug repurposing in the treatment of muscular dystrophies 69
Continuous production of polymeric nanocapsules through confined impinging jets mixers 68
Preparazione e direzionamento attivo di nanoparticelle biodegradabili ad emivita plasmatica prolungata per la somministrazione di sostanze ad attività antitumorale 67
Hyaluronan liposomes for antitumor drug delivery 67
Nanoparticles of Therapeutic agents having low water solubility (US extension) 67
Gemcitabine derivatives nanoparticles 66
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 66
Preparation and characterization of novel PEG-paclitaxel derivatives 66
Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse (JP extension) 66
Incorporation of squalenoyl doxorubicin into solid lipid nanoparticles 66
Gemcitabine derivatives nanoparticles 65
Incorporation of lipophilic gemcitabine prodrugs in liposomes 65
Ciblage tumorale intracellulaire à l’aide de l’acide folique couplé aux nanoparticules ‘peggylées’ 65
Novel nanoassemblies of potent anticancer compounds by conjugation with squalene moiety 65
An ex vivo experimental system to track fluorescent nanoparticles inside skeletal muscle 64
Squalenic nanoparticles with active targeting: in vivo results 64
Nanoparticles of Gemcitabine derivatives 64
Zeta potential measurements on solid surfaces for in Vitro biomaterials testing: Surface charge, reactivity upon contact with fluids and protein absorption 64
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 63
Squalenoylation platform for novel therapeutic nanoassemblies 63
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization. 63
New difluoro-2'-deoxycytidine derivatives, useful as anticancer and antiviral agents, contain residue that promotes formation of nanoparticles and increases stability in serum 62
NANOPARTICLES OF THERAPEUTIC AGENTS HAVING LOW WATER SOLUBILITY 62
Totale 10.943
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.851
article - articoli 0
book - libri 0
conference - conferenze 18.233
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.084
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020894 0 0 0 0 0 0 194 126 210 173 102 89
2020/20211.717 191 100 131 66 144 85 205 68 215 170 162 180
2021/20222.067 64 79 68 163 89 80 145 159 58 129 612 421
2022/20232.391 236 148 51 217 215 658 270 134 244 43 126 49
2023/20241.147 108 208 78 68 81 119 52 61 14 92 94 172
2024/20252.214 654 167 112 252 816 200 13 0 0 0 0 0
Totale 14.764